Related Experiment Video
Updated: Apr 5, 2026

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases
Annalisa Schiepatti1, Federico Biagi1, Davide Cumetti2
1a First Department of Internal Medicine , Fondazione IRCCS Policlinico San Matteo, University of Pavia , Pavia , Italy .
Introduction:
The association between olmesartan and an enteropathy histologically indistinguishable from untreated celiac disease has recently been described. However, pathogenetic mechanisms leading to villous atrophy, prevalence, natural history and genetic background of this condition have not yet been defined.
Patients:
We describe here two cases of olmesartan-associated enteropathy and discuss some aspects of the natural history of this condition.
Results:
In both patients, an infectious episode seems to have triggered the severe malabsorption syndrome which led them to hospitalization. High titer positive antinuclear antibodies with homogeneous pattern were found.
Conclusions:
Our reports add to a growing body of evidence suggesting that olmesartan-associated enteropathy should be considered in the presence of villous atrophy and negative celiac serology and in the diagnostic algorithm of non-responsive celiac disease.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Potassium-Sparing Diuretics
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
